| pubmed-article:17200219 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17200219 | lifeskim:mentions | umls-concept:C0001675 | lld:lifeskim |
| pubmed-article:17200219 | lifeskim:mentions | umls-concept:C0043117 | lld:lifeskim |
| pubmed-article:17200219 | lifeskim:mentions | umls-concept:C0393022 | lld:lifeskim |
| pubmed-article:17200219 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
| pubmed-article:17200219 | lifeskim:mentions | umls-concept:C1955832 | lld:lifeskim |
| pubmed-article:17200219 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:17200219 | pubmed:dateCreated | 2007-1-3 | lld:pubmed |
| pubmed-article:17200219 | pubmed:abstractText | Rituximab, a monoclonal anti-CD20 antibody, is increasingly used to treat idiopathic thrombocytopenic purpura (ITP). | lld:pubmed |
| pubmed-article:17200219 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17200219 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17200219 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17200219 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:17200219 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17200219 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17200219 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17200219 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17200219 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17200219 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17200219 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:17200219 | pubmed:issn | 1539-3704 | lld:pubmed |
| pubmed-article:17200219 | pubmed:author | pubmed-author:CrowtherMark... | lld:pubmed |
| pubmed-article:17200219 | pubmed:author | pubmed-author:MeyerRalph... | lld:pubmed |
| pubmed-article:17200219 | pubmed:author | pubmed-author:CookRichard... | lld:pubmed |
| pubmed-article:17200219 | pubmed:author | pubmed-author:DentaliFrance... | lld:pubmed |
| pubmed-article:17200219 | pubmed:author | pubmed-author:KeltonJohn... | lld:pubmed |
| pubmed-article:17200219 | pubmed:author | pubmed-author:SigouinChrist... | lld:pubmed |
| pubmed-article:17200219 | pubmed:author | pubmed-author:LimWendyW | lld:pubmed |
| pubmed-article:17200219 | pubmed:author | pubmed-author:ArnoldDonald... | lld:pubmed |
| pubmed-article:17200219 | pubmed:author | pubmed-author:FraserGraeme... | lld:pubmed |
| pubmed-article:17200219 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:17200219 | pubmed:day | 2 | lld:pubmed |
| pubmed-article:17200219 | pubmed:volume | 146 | lld:pubmed |
| pubmed-article:17200219 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17200219 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17200219 | pubmed:pagination | 25-33 | lld:pubmed |
| pubmed-article:17200219 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:17200219 | pubmed:meshHeading | pubmed-meshheading:17200219... | lld:pubmed |
| pubmed-article:17200219 | pubmed:meshHeading | pubmed-meshheading:17200219... | lld:pubmed |
| pubmed-article:17200219 | pubmed:meshHeading | pubmed-meshheading:17200219... | lld:pubmed |
| pubmed-article:17200219 | pubmed:meshHeading | pubmed-meshheading:17200219... | lld:pubmed |
| pubmed-article:17200219 | pubmed:meshHeading | pubmed-meshheading:17200219... | lld:pubmed |
| pubmed-article:17200219 | pubmed:meshHeading | pubmed-meshheading:17200219... | lld:pubmed |
| pubmed-article:17200219 | pubmed:meshHeading | pubmed-meshheading:17200219... | lld:pubmed |
| pubmed-article:17200219 | pubmed:meshHeading | pubmed-meshheading:17200219... | lld:pubmed |
| pubmed-article:17200219 | pubmed:meshHeading | pubmed-meshheading:17200219... | lld:pubmed |
| pubmed-article:17200219 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17200219 | pubmed:articleTitle | Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. | lld:pubmed |
| pubmed-article:17200219 | pubmed:affiliation | McMaster University and Juravinski Cancer Centre, Hamilton, Ontario, Canada. arnold@mcmaster.ca | lld:pubmed |
| pubmed-article:17200219 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17200219 | pubmed:publicationType | Review | lld:pubmed |
| pubmed-article:17200219 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17200219 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17200219 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17200219 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17200219 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17200219 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17200219 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17200219 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17200219 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17200219 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17200219 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17200219 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17200219 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17200219 | lld:pubmed |
